Ovarian Cancer
Mystery of the missing breast cancer genes
Researchers from the University of Adelaide are hoping to better understand why the mutated genes for breast and ovarian cancer are not passed on more frequently from one generation of women to the next.
Genetics
May 08, 2012 |
not rated yet |
0
|
DNA repair pathway score for predicting chemotherapy response in ovarian cancer patients
A DNA repair pathway-focused score has the potential to help determine if first-line platinum based chemotherapy can benefit advanced-stage ovarian cancer patients, according to a study published April 13 in the Journal of ...
Cancer
Apr 13, 2012 |
5 / 5 (3) |
0
|
Pox vaccines extend survival for patients with melanoma, ovarian cancer
An immunotherapy regimen incorporating poxviruses and targeting a particular tumor antigen, NY-ESO-1, has shown promise in treating two types of cancers. Kunle Odunsi, MD, PhD, Chair of the Department of Gynecologic Oncology ...
Cancer
Mar 26, 2012 |
5 / 5 (1) |
0
|
High court throws out human gene patents
(AP) -- The Supreme Court on Monday threw out a lower court ruling allowing human genes to be patented, a topic of enormous interest to cancer researchers, patients and drug makers.
Genetics
Mar 26, 2012 |
5 / 5 (3) |
1
Study role testosterone may play in triple negative breast cancer
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. ...
Cancer
Mar 23, 2012 |
5 / 5 (1) |
0
|
DNA marker predicts platinum drug response in breast, ovarian cancer
Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will ...
Cancer
Mar 22, 2012 |
4.7 / 5 (3) |
0
|
Study reveals contraceptive cancer risks
A study has revealed that injectable contraceptives that are widely used around the world influence the risk of developing several types of cancer.
Cancer
Mar 07, 2012 |
not rated yet |
0
|
Researchers find possible genetic keys to surviving epithelial ovarian cancer
Researchers at Moffitt Cancer Center and colleagues from 11 other institutions in the United States and the United Kingdom have used two genome-wide association studies (GWAS) – one from the U.S. and one from the U.K. ...
Cancer
Mar 06, 2012 |
5 / 5 (2) |
0
|
Traitorous immune cells promote sudden ovarian cancer progression
Aggressive ovarian tumors begin as malignant cells kept in check by the immune system until, suddenly and unpredictably, they explode into metastatic cancer. New findings from scientists at The Wistar Institute demonstrate ...
Cancer
Feb 20, 2012 |
5 / 5 (1) |
0
|
Ovarian cancer arises in fallopian tube of knockout mice
(Medical Xpress) -- The most deadly form of "ovarian" cancer arises in the fallopian tubes – not the ovaries – of knockout mice that lack two genes associated with the disease, said researchers led by Baylor College ...
Cancer
Feb 13, 2012 |
not rated yet |
0
|
Molecular profiling reveals differences between primary and recurrent ovarian cancers
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine ...
Cancer
Feb 10, 2012 |
not rated yet |
0
|
Ovarian cancer risk related to inherited inflammation genes
In a study conducted by researchers at Moffitt Cancer Center and colleagues from 11 other institutions in the Unites States and the United Kingdom, genes that are known to be involved in inflammation were found to be related ...
Cancer
Feb 07, 2012 |
5 / 5 (1) |
0
|
Predicting the value of indexing symptoms for ovarian cancer
The use of symptom indices to identify patients with symptoms associated with ovarian cancer who may need further screening is increasing in both the UK and the US in an attempt to promote earlier diagnosis, but they may ...
Cancer
Jan 14, 2012 |
not rated yet |
0
|
Faulty proteins may prove significant in identifying new treatments for ovarian cancer
A constellation of defective proteins suspected in causing a malfunction in the body's ability to repair its own DNA could be the link scientists need to prove a new class of drugs will be effective in treating a broad range ...
Cancer
Jan 13, 2012 |
4 / 5 (1) |
0
|
Targeted therapy extends progression-free survival of patients with advanced ovarian cancer
Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic ...
Cancer
Dec 28, 2011 |
not rated yet |
0
|
Ovarian cancer is a cancerous growth arising from the ovary. Symptoms are frequently very subtle early on and may include: bloating, pelvic pain, difficulty eating and frequent urination, and are easily confused with other illnesses.
Most (more than 90%) ovarian cancers are classified as "epithelial" and are believed to arise from the surface (epithelium) of the ovary. However, some evidence suggests that the fallopian tube could also be the source of some ovarian cancers. Since the ovaries and tubes are closely related to each other, it is thought that these fallopian cancer cells can mimic ovarian cancer. Other types may arise from the egg cells (germ cell tumor) or supporting cells. These cancers are grouped into the category of gynecologic cancer.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
Study says empathy plays a key role in moral judgments
Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...
Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens
Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Drugs found to both prevent and treat Alzheimer's disease in mice
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
Study finds vitamin C can kill drug-resistant TB (w/ video)
In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding ...
